Research And Development
100 Most Popular
Most Popular Under $25

TransEnterix

$2.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.14 (-5.93%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell TransEnterix and other stocks, options, ETFs, and crypto commission-free!

About

TransEnterix, Inc., also called TransEnterix, is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. Read More It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.

Employees
189
Headquarters
Morrisville, North Carolina
Founded
2006
Market Cap
480.29M
Price-Earnings Ratio
β€”
Dividend Yield
0.00
Average Volume
4.97M
High Today
$2.35
Low Today
$2.22
Open Price
$2.32
Volume
974.43K
52 Week High
$6.98
52 Week Low
$1.60

Collections

Research And Development
100 Most Popular
Most Popular Under $25
Medical Devices
Medical
Health
US
North America

News

Simply Wall StMar 7

How Many TransEnterix, Inc. (NYSEMKT:TRXC) Shares Do Institutions Own?

Every investor in TransEnterix, Inc. (NYSEMKT:TRXC) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it’s not unusual to see insiders own a fair bit of smaller companies. Companies that have been privatized tend to have low insider ownership. With a market capitalization of US$538m, TransEnterix is a small cap stock, so it might not be well known by many institutional investors. In the chart below below, we can see that institutions...

1,164
The Motley FoolFeb 26

TransEnterix (TRXC) Q4 2018 Earnings Conference Call Transcript

TransEnterix (AMEX:TRXC) Q4 2018 Earnings Conference Call Feb. 26, 2019 8:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good afternoon, ladies and gentlemen. Welcome to the TransEnterix fourth-quarter and full-year 2018 financial and operating results conference call. As a reminder, this conference call is webcast live and recorded. It is now pleasure to introduce your host Mr. Mark Klausner of Westwicke Partners. Please go ahead, sir. Ma...

2,955
Seeking AlphaFeb 26

TransEnterix, Inc. (TRXC) CEO Todd Pope on Q4 2018 Results - Earnings Call Transcript

TransEnterix, Inc. (NYSEMKT:TRXC) Q4 2018 Earnings Conference Call February 26, 2019 8:00 AM ET Company Participants Mark Klausner - Investor Relations Todd Pope - President and Chief Executive Officer Joe Slattery - Executive Vice President and Chief Financial Officer Conference Call Participants Rick Wise - Stifel Glenn Novarro - RBC Capital Markets Larry Keusch - Raymond James Operator Good afternoon, ladies and gentlemen. Welcome to the TransEnterix Fourth Quarter and Full Year 2018 Financial ...

964

Earnings

-$0.11
-$0.09
-$0.08
-$0.06
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
β€”
Actual
Expected May 8, Pre-Market

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.